BMRN vs SFD · P/E 40, rev $1.76B vs P/E 9.6, rev $14.14B
Biomarin Pharmaceutical Inc (BMRN) versus Smithfield Foods, Inc. Common Stock (SFD) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Smithfield Foods, Inc. Common Stock (SFD) is a packaged foods company listed on NASDAQ.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported SFD revenue for 2024-12-29 was $14.14B. Net income was $970.0M. Revenue was down 3.4% from 2023-12-31 to 2024-12-29. SFD currently screens at market cap $9.75B and trailing P/E 9.6.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. SFD currently screens at market cap $9.75B and trailing P/E 9.6.
Not investment advice. Open the BMRN and SFD stock pages for the full models.
Not investment advice.